In this episode, we chatted with Melanie Ivarsson, Chief Development Officer at Moderna, who led teams in times the world was anxiously waiting for them to deliver us a hope with Covid Vaccine… and they did. How did they achieve this? How do you lead in such unprecedented times? How do you ensure this sense of purpose continues to live today? Hear all about those stories and about Melanie’s biggest leadership learning throughout this once-in-a-lifetime experience: Enable others to be the best they can be, and don’t get in their way.
Melanie Ivarsson is Senior Vice President, Chief Development Officer at Moderna, where she leads the Clinical Development Operations department. In this role Dr Ivarsson and her team deliver all clinical programs within the Moderna portfolio.
Melanie has more than 20 years of experience in the pharmaceutical industry. Prior to joining Moderna, she was Head of Global Clinical Operations, at Takeda (following the acquisition of Shire) and spent 9 years at Pfizer in Clinical Development. She also held roles within the early clinical development group at Eli Lilly.
After receiving her PhD from the University of Bristol, she completed postdoctoral research at Lund University and New York University. Dr Ivarsson also holds an Executive MBA from MIT Sloan School of Management.
Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love. I am Naji, your host today, having the pleasure to be joined by Melanie Ivarsson Chief Development Officer at Moderna. In this role Melanie leads the Clinical Development Operations department and delivers with her team all clinical programs within the Moderna portfolio. Prior to joining Moderna, she was Head of Global Clinical Operations at Takeda and spent 9 years at Pfizer in…
Careers are a mix of decisions, serendipity, and chance. At least for Dr. Shahin Gharakhanian, this is his belief about his career reflecting his humility. Innovation is about “daring”. Through this chat, you’ll hear from a physician, a pharmaceutical expert, and a leader who lived through one of the most challenging outbreaks of HIV since its very beginnings and led teams who developed life-saving drugs. His deep belief is anchored in “doing well by doing good”, this is a constant motivation that we should all have in biotech. For Shahin, as biopharma leaders, we should have 3 facets: being an inspirational leader, a strong administrator, and a great manager. Hear more about the mix of those three capabilities, incredible other stories, and powerful words of wisdom in this episode!
Dr. Shahin Gharakhanian is a physician and Pharmaceutical Executive with expertise in Pharmaceutical Medicine, Leadership/Management, and operational experience both in the US & in Europe.
Shahin is specialized in HIV Medicine and Infectious Diseases and has practiced clinical medicine for over 20 years in AP-HP Hospitals in Paris France. Shahin joined the pharmaceutical industry in 1991, progressing to Vice-President of Vertex Pharmaceuticals, with roles in 3 main areas: Clinical Development, Medical Affairs, and Strategic Leadership including membership in the corporate Operating Council. Overall, within the industry, he has held positions ranging from General Manager of a Contract Research Organization to Program Executive leading product development, and regulatory approval/launch in multiple therapeutic areas across the world. Shahin has also founded, built, and organized full functional departments/units for biotechnology companies and hospitals and two LLCs as an entrepreneur.
He is a member of several international societies. His passion is Patient-focused programs for drug & vaccine development, approval, and launch.
Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love. I am Naji, your host for this podcast, having the pleasure to be joined by Dr. Shahin Gharakhanian, a physician and Pharmaceutical Executive with expertise in Pharmaceutical Medicine, Leadership/Management, and operational experience both in the US & in Europe. Shahin is specialized in HIV Medicine and Infectious Diseases has practiced clinical medicine for over 20 years in AP-HP Hospitals in Paris France.…
In this episode, you’ll hear from a serial biotech entrepreneur and incredible leader Pravin Chaturvedi. Many insightful words I kept with me from this episode as a leader in healthcare: Strive to Impact, not Impress. Life is short when you’re happy, long when you’re suffering. Never tolerate oppression of any form. Residual intellect. Powerpoint is useless :). Hear more about those leadership beliefs Pravin shared with us and also his experience in building biotech companies and teams. He left us with a powerful charge as healthcare leaders: “Never forget our huge responsibility: Patients rely on us to make their life better.” If this is not why you wake up every morning and strive for, you’re in the wrong industry.
Pravin Chaturvedi is a veteran drug developer, serial biotech entrepreneur, and seasoned CEO. CSO and/or Board member of many life science ventures. Over his 30+ years in the biotech and pharmaceutical industry, he has participated in and led the drug development teams for multiple drugs across the therapeutic areas of central nervous system (CNS), HIV, hepatitis C virus (HCV), cancer, and gastrointestinal disorders. He has participated in the successful drug approval and commercialization of seven drugs.
Pravin serves as the Chairman of the Scientific Advisory Board (SAB) and Chief Scientific Officer (CSO) for Napo Pharmaceuticals and Jaguar Health. He is also the co-founder and CEO of IndUS Pharmaceuticals and Oceanyx Pharmaceuticals. He is also the Executive Chairman of Cellanyx and Chair of the Board for Enlivity. He currently serves on the boards of several organizations including IndUS, Oceanyx, Cellanyx, Enlivity, and Sindu Research Laboratories. He has previously served as the President, CEO, and Board of Director for Pivot Pharmaceuticals and Scion Pharmaceuticals and has also served on the boards of Pivot, Scion, Bach Pharma, PRADAN USA, FuelEd Schools, Sindu Pharmaceuticals, TiE Boston, and ResoluteBio. Over his career, he has also been a part of multiple national and international strategic partnerships with large pharmaceutical companies as well as governments and has served on several advisory boards.
Prior to his current leadership responsibilities as (President/CEO/CSO roles in various companies), he served as the Head of Lead Evaluation at Vertex Pharmaceuticals. He held scientific positions at Alkermes and Parke-Davis/Warner-Lambert (now Pfizer). He also contributes significant time to teaching and serves as an adjunct faculty member at Georgetown Medical School. He holds a doctoral degree from West Virginia University and an undergraduate degree in pharmacy from the University of Bombay.
Naji Gehchan: Hello, leaders of the world. Welcome to spread love in organizations, the podcast for purpose-driven healthcare leaders, striving to make life better around the world by leading their teams with genuine care, servant leadership, and love. I am Naji, your host for this podcast, having the pleasure to be joined by Dr Pravin Chaturvedi a veteran drug developer, serial biotech entrepreneur, and seasoned CEO/CSO, Board member of many life science ventures. Over his 30+ years in the biotech and pharmaceutical industry, he has participated and led the drug development teams for multiple drugs across the several therapeutic areas.…
“What really matters is impact”. Marcello Damiani started with this statement, and we all know now the impact he and his teams at Moderna had on humanity over the past years. He has led teams through those times, delivered on an incredible challenge that became a hope, then a reality: Covid vaccines. Hear him share those stories, his learning, the role of leadership, digital, innovation… From the focus on purpose to the culture and mindset to deliver on it, Marcello gives us great words of wisdom as we continue to navigate times of uncertainty and change. Let’s “not be shy to take risks to impact the world”!
“A leader alone doesn’t serve any purpose”
MEET OUR GUESTMarcello Damiani, Chief Digital and Operational Excellence Officer at Moderna.
Marcello Damiani is the Chief Digital and Operational Excellence Officer at Moderna, where he builds the technology, processes, and digitization landscape required to advance a new class of medicines based on mRNA science. Marcello has a wealth of experience from both Tech and Life Science companies, with a true passion for making digital a reality. He has 20years experience working in the IT field, with the last 10years being spent in leadership roles for multinational companies in Europe and the USA. Prior to joining Moderna, he worked at diagnostics firm bioMérieux and before that at Motorola.
Marcello has a Master of Science degree in Information and Communication Systems Architecture from the University of Toulouse in France, and an Executive MBA through TRIUM.